Modified quadruple therapy versus bismuth-containing quadruple therapy in first-line treatment of Helicobacter pylori infection in Korea; rationale and design of an open-label, multicenter, randomized controlled trial

BACKGROUND: Clarithromycin-containing triple regimen for eradication of Helicobacter pylori is no longer acceptable in Korea due to high clarithromycin resistance. Concomitant therapy or bismuth-containing quadruple therapy is recommended as an alternative regimen. A recent study in Korea has shown...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: Lim, Hyun, Bang, Chang Seok, Shin, Woon Geon, Choi, Jae Ho, Soh, Jae Seung, Kang, Ho Suk, Yang, Young Joo, Hong, Ji Taek, Shin, Suk Pyo, Suk, Ki Tae, Lee, Jae Jun, Baik, Gwang Ho, Kim, Dong Joon
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6257664/
https://ncbi.nlm.nih.gov/pubmed/30431605
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000013245
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados